Mumbai, Aug. 26 -- While the counterparties were not disclosed, media reports suggested that private equity firm TPG Asia likely sold its entire stake in the company through the transaction, with shares changing hands at Rs 874 apiece. Final details of the deal, however, remain unconfirmed.

TPG Asia was earlier reported to be preparing a full divestment of its stake, estimated at about 3.07 crore shares or 14.72% of Sai Life's equity capital. The deal is seen as a clean-up trade marking a complete exit for the investor, which has backed the Hyderabad-based firm for several years.

Hyderabad-based Sai Life Sciences is a Contract Research, Development and Manufacturing Organization (CRDMO) that works with pharmaceutical and biotechnology c...